Jefferies (JEF) Q1 2026 Earnings: Record Investment Banking Quarter Undermined by One-Time Charges
Jefferies posted $2.02B in Q1 2026 revenue, up 26.6% YoY, with a record IB quarter of $1.02B (+45%). But a $36M goodwill write-down and legacy asset losses dragged GAAP EPS to $0.70 — well below the $0.91 estimate. The stock, already down 45% from its highs, now trades at just 13x forward earnings.
Key points
- Jefferies posted $2.02B in Q1 2026 revenue, up 26.6% YoY, with a record IB quarter of $1.02B (+45%). But a $36M goodwill write-down and legacy asset losses dragged GAAP EPS to $0.70 — well below the $0.91 estimate. The stock, already down 45% from its highs, now trades at just 13x forward earnings.
Jefferies Financial Group ($JEF) just delivered its best investment banking quarter in the firm’s history — $1.02 billion in IB net revenues, up 45% year-over-year — and yet the stock barely moved, closing down roughly 1.8% to $39.27 on the day.
That’s the Jefferies paradox entering 2026: a franchise that is structurally winning market share in investment banking and equities, generating record revenues across its core businesses, while one-time write-downs and legacy divestiture losses continue to obscure the underlying earnings power. With the stock having fallen from an all-time high above $71 to the high-$30s, the market is asking a pointed question: are the one-time items truly one-time, or is Jefferies perpetually impaired by its non-core legacy assets?
Results at a Glance
| Metric | Q1 2026 Actual | Consensus Estimate | vs. Estimate |
|---|---|---|---|
| Total Net Revenue | $2.02B | $1.99B | +1.4% beat |
| GAAP EPS | $0.70 | $0.91 | −23.3% miss |
| Net Earnings | $155.7M | — | +21.8% YoY |
| Investment Banking Revenue | $1.02B | — | +45% YoY |
| Equities Revenue | $558.5M | — | +36.5% YoY (record Q1) |
| Pre-Tax Income | $212.2M | — | 10.5% margin |
| TBVPS | $34.24 | $34.53 | −0.8% miss |
The one-time drag: A non-cash goodwill write-down of ~$36 million (after-tax) tied to the Tessellis business, plus $17 million in losses from Market Financial Solutions and First Brands legacy assets. Together, these items cost approximately $0.26 per diluted share — nearly the entire EPS miss. Strip them out, and Jefferies would have reported roughly $0.96 in underlying EPS, ahead of consensus.
Revenue: A Cyclical Recovery Reaching New Heights
Jefferies’ revenue story is one of the sharpest V-shaped recoveries in investment banking. After the 2021 bull market drove revenues to an all-time high of $8.01 billion, a brutal combination of rising interest rates, frozen IPO markets, and deal-making paralysis sent revenues crashing to $4.70 billion in FY2023. The recovery that followed — $7.04 billion in FY2024, $7.34 billion in FY2025 — suggests the franchise emerged from the downturn structurally stronger, not weaker.
Annual Net Revenue (in $B) — FY2021 to FY2025
FY ends November 30. Lighter bars reflect the 2022–2023 downturn trough.
Q1 2026 annualized revenue of ~$8.1 billion would represent a new all-time high for the firm. The pace of deal-making recovery — global M&A volume up 27% year-over-year in Q1 — is directly feeding Jefferies’ IB pipeline, and management called the activity levels “very strong” heading into Q2.
Net Income: The Earnings Recovery Story
While revenue has nearly recovered to peak levels, net income tells a more nuanced story. FY2023 produced only $263 million in net income — a fraction of the $777 million generated in FY2022 despite lower revenue — partly due to accelerated write-downs and restructuring charges as Jefferies exited non-core businesses. FY2024 and FY2025 saw a meaningful recovery to ~$670 million annually, but legacy-asset drag continues to prevent net income from fully reflecting the operational strength.
Annual Net Income (in $M) — FY2021 to FY2025
FY2021 net income is estimated based on record ROE of 24.5% and reported equity base. FY ends November 30.
The gap between revenue recovery ($8B+) and net income recovery (~$680M vs. ~$1.5B peak) is almost entirely attributable to the legacy Leucadia National assets that Jefferies has been divesting since the 2018 rebranding. Once those write-downs run their course, the underlying earnings power of the core IB + capital markets franchise should re-rate meaningfully.
Segment Revenue: Where the Money Is Coming From
The Q1 2026 results show a remarkable step-up in the firm’s two most important revenue drivers.
Q1 2026 Net Revenue by Segment (in $M)
Fixed Income/Other is implied (Capital Markets total $779M less Equities $558.5M). Data for Q1 2026 only.
Investment Banking at $1.02 billion marks the firm’s highest-ever quarterly IB revenue, driven by a surge in M&A advisory fees as pent-up deal activity from 2022–2023 has finally started closing. The global M&A boom that Jefferies telegraphed throughout 2025 is materializing in billings.
Equities at $558.5 million also set a Q1 record, driven by market share gains in options, corporate derivatives, and global electronic trading. The 36.5% year-over-year growth outpaced virtually every large-cap broker-dealer for the quarter.
Capital Allocation: Buying Back Stock at $58 — When It Now Trades at $39
One of the most striking data points in the Q1 release: Jefferies repurchased 3.0 million shares at an average price of $58.18 per share, totaling $174 million. The stock closed at $39.27 on March 26. That means management spent corporate capital at a price 48% above where the stock trades today, raising legitimate questions about buyback discipline.
To be fair, some of these purchases may have been at earlier prices before the stock’s recent decline. But it highlights the challenge: Jefferies’ management sees substantial value at $58 per share, the market disagrees at $39, and analysts have a consensus target of $71.
The board increased the share repurchase authorization back to $250 million remaining — signaling management confidence that the current price represents significant undervaluation. They may be right, but timing matters.
Strategic Position: The “Pure-Play IB” Thesis
Jefferies has spent the better part of eight years unwinding the Leucadia National legacy, a sprawling conglomerate that owned everything from beef processors to oil & gas exploration companies. The transformation to a “pure-play investment banking and capital markets firm” is nearly complete — and Q1 2026 is the clearest demonstration of what that franchise looks like at full power.
The M&A tailwind is real. Global M&A volume surged 27% year-over-year in Q1 2026, crossing $1 trillion in a single quarter for the first time since the 2021 boom. Jefferies is no longer a mid-tier boutique fighting for scraps — it has built industry-leading practices in healthcare, technology, and energy M&A that now win mandates alongside Goldman Sachs and Morgan Stanley.
The Tessellis write-down (the $36M non-cash charge) is an irritant, not an indictment. It represents the final accounting cleanup on a legacy financial services business that never fit the pure-play vision. Once it’s gone, it’s gone.
The headwind: Higher effective tax rate (24.9%) and continued mark-to-market losses on the First Brands and Market Financial Solutions positions. Management has been exiting these positions for years; when they’re fully wound down, the tax rate normalizes and the earnings drag disappears.
Valuation
| Metric | Value |
|---|---|
| Share Price (Mar 26) | ~$39.27 |
| Market Cap | ~$8.1B |
| Enterprise Value | ~$9.9B (est.) |
| TTM Net Income | ~$682M |
| P/E (TTM) | ~12x |
| Forward P/E | ~13.3x |
| Price / Tangible Book Value | ~1.15x |
| Dividend Yield | ~4.1% ($1.60/share annualized) |
| Median Analyst Price Target | $71.00 |
| Implied Upside | ~81% |
The bull case: At 13x forward earnings and 1.15x tangible book, Jefferies is priced for ongoing impairment — not for a firm posting record IB revenues and growing equities market share. The M&A cycle that drove $8.01 billion in FY2021 revenue is returning. If one-time charges genuinely wind down in FY2026, the earnings power of $900M–$1.1B annually becomes visible, implying a stock price of $55–$70 at current multiples. The analyst consensus target of $71 represents 81% upside from current levels.
The bear case: The persistent gap between “adjusted” and GAAP earnings is a yellow flag. Every quarter for the last several years has included some form of write-down or legacy loss. If this continues indefinitely, the “underlying earnings power” story never translates to GAAP reality. Meanwhile, the stock was near $70 just a year ago — what has fundamentally changed? Rising interest rates could dampen the M&A recovery, and concentration in advisory and equities leaves Jefferies exposed to deal-flow volatility.
What to watch Q2 2026:
- IB pipeline conversion — does the record Q1 advisory book translate into Q2 billings at sustained levels?
- Legacy asset resolution — are the Tessellis and First Brands positions finally off the books?
- Tax rate normalization — does the 24.9% effective rate come down toward 22–23% as legacy businesses exit?
Jefferies’ Q1 2026 is the firm firing on all cylinders in its core businesses. The question is whether management can finally clear the legacy debris and let that operational excellence translate to the bottom line.
This article is for informational purposes only and does not constitute investment advice. Always do your own research before making investment decisions.
Tickertimes articles are for information only and are not financial, investment, tax, or legal advice.